Literature DB >> 18658153

The switch I region of Rheb is critical for its interaction with FKBP38.

Dongzhu Ma1, Xiaochun Bai, Shuguang Guo, Yu Jiang.   

Abstract

The Ras-like small GTPase Rheb is an upstream activator of the mammalian target of rapamycin (mTOR). It has recently been shown that Rheb activates mTOR by binding to its endogenous inhibitor FKBP38 and preventing it from association with mTOR. The interaction of Rheb with FKBP38 is controlled by its guanine nucleotide binding states, which are responsive to growth factor and amino acid conditions. In this study, we show that Rheb interacts with FKBP38 through a section within its switch I region that is equivalent to the effector domain of other Ras-like small GTPases. We find that the ability for Rheb to interact with FKBP38 correlates with its activity for mTOR activation. Our findings suggest that FKBP38 is a bona fide effector of Rheb and that the ability to interact with FKBP38 is important for Rheb as an activator of mTOR.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18658153      PMCID: PMC2533802          DOI: 10.1074/jbc.M802356200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  36 in total

Review 1.  FKBPs: at the crossroads of folding and transduction.

Authors:  Y Harrar; C Bellini; J D Faure
Journal:  Trends Plant Sci       Date:  2001-09       Impact factor: 18.313

2.  Predominant nuclear localization of mammalian target of rapamycin in normal and malignant cells in culture.

Authors:  Xiongwen Zhang; Lili Shu; Hajime Hosoi; K Gopal Murti; Peter J Houghton
Journal:  J Biol Chem       Date:  2002-05-08       Impact factor: 5.157

3.  FKBP12-rapamycin-associated protein associates with mitochondria and senses osmotic stress via mitochondrial dysfunction.

Authors:  Bimal N Desai; Benjamin R Myers; Stuart L Schreiber
Journal:  Proc Natl Acad Sci U S A       Date:  2002-04-02       Impact factor: 11.205

4.  Rheb activates mTOR by antagonizing its endogenous inhibitor, FKBP38.

Authors:  Xiaochun Bai; Dongzhu Ma; Anling Liu; Xiaoyun Shen; Qiming J Wang; Yongjian Liu; Yu Jiang
Journal:  Science       Date:  2007-11-09       Impact factor: 47.728

5.  Identification of dominant negative mutants of Rheb GTPase and their use to implicate the involvement of human Rheb in the activation of p70S6K.

Authors:  Angel P Tabancay; Chia-Ling Gau; Iara M P Machado; Erik J Uhlmann; David H Gutmann; Lea Guo; Fuyuhiko Tamanoi
Journal:  J Biol Chem       Date:  2003-07-17       Impact factor: 5.157

6.  Rheb is a direct target of the tuberous sclerosis tumour suppressor proteins.

Authors:  Yong Zhang; Xinsheng Gao; Leslie J Saucedo; Binggen Ru; Bruce A Edgar; Duojia Pan
Journal:  Nat Cell Biol       Date:  2003-06       Impact factor: 28.824

7.  Rheb is an essential regulator of S6K in controlling cell growth in Drosophila.

Authors:  Hugo Stocker; Thomas Radimerski; Benno Schindelholz; Franz Wittwer; Priyanka Belawat; Pierre Daram; Sebastian Breuer; George Thomas; Ernst Hafen
Journal:  Nat Cell Biol       Date:  2003-06       Impact factor: 28.824

8.  Rheb promotes cell growth as a component of the insulin/TOR signalling network.

Authors:  Leslie J Saucedo; Xinsheng Gao; Dominic A Chiarelli; Ling Li; Duoija Pan; Bruce A Edgar
Journal:  Nat Cell Biol       Date:  2003-06       Impact factor: 28.824

9.  Inherent calcineurin inhibitor FKBP38 targets Bcl-2 to mitochondria and inhibits apoptosis.

Authors:  Michiko Shirane; Keiichi I Nakayama
Journal:  Nat Cell Biol       Date:  2003-01       Impact factor: 28.824

10.  Insulin activation of Rheb, a mediator of mTOR/S6K/4E-BP signaling, is inhibited by TSC1 and 2.

Authors:  Attila Garami; Fried J T Zwartkruis; Takahiro Nobukuni; Manel Joaquin; Marta Roccio; Hugo Stocker; Sara C Kozma; Ernst Hafen; Johannes L Bos; George Thomas
Journal:  Mol Cell       Date:  2003-06       Impact factor: 17.970

View more
  24 in total

1.  The FKBP38 catalytic domain binds to Bcl-2 via a charge-sensitive loop.

Authors:  Katja Haupt; Günther Jahreis; Miriam Linnert; Mitcheell Maestre-Martínez; Miroslav Malesevic; Arndt Pechstein; Frank Edlich; Christian Lücke
Journal:  J Biol Chem       Date:  2012-04-20       Impact factor: 5.157

2.  The abundance and activation of mTORC1 regulators in skeletal muscle of neonatal pigs are modulated by insulin, amino acids, and age.

Authors:  Agus Suryawan; Teresa A Davis
Journal:  J Appl Physiol (1985)       Date:  2010-08-19

3.  FKBPs and the Akt/mTOR pathway.

Authors:  Felix Hausch; Christian Kozany; Marily Theodoropoulou; Anne-Katrin Fabian
Journal:  Cell Cycle       Date:  2013-07-01       Impact factor: 4.534

Review 4.  Regulation of mTORC1 by PI3K signaling.

Authors:  Christian C Dibble; Lewis C Cantley
Journal:  Trends Cell Biol       Date:  2015-07-06       Impact factor: 20.808

Review 5.  Recent progress in the study of the Rheb family GTPases.

Authors:  Jeffrey J Heard; Valerie Fong; S Zahra Bathaie; Fuyuhiko Tamanoi
Journal:  Cell Signal       Date:  2014-05-24       Impact factor: 4.315

6.  Target of rapamycin FATC domain as a general membrane anchor: The FKBP-12 like domain of FKBP38 as a case study.

Authors:  Maristella De Cicco; Lech-G Milroy; Sonja A Dames
Journal:  Protein Sci       Date:  2017-10-30       Impact factor: 6.725

Review 7.  mTOR signaling in lymphangioleiomyomatosis.

Authors:  Arnold S Kristof
Journal:  Lymphat Res Biol       Date:  2010-03       Impact factor: 2.589

8.  Specific activation of mTORC1 by Rheb G-protein in vitro involves enhanced recruitment of its substrate protein.

Authors:  Tatsuhiro Sato; Akio Nakashima; Lea Guo; Fuyuhiko Tamanoi
Journal:  J Biol Chem       Date:  2009-03-19       Impact factor: 5.157

Review 9.  Proinflammatory stem cell signaling in cardiac ischemia.

Authors:  Jeremy L Herrmann; Troy A Markel; Aaron M Abarbanell; Brent R Weil; Meijing Wang; Yue Wang; Jiangning Tan; Daniel R Meldrum
Journal:  Antioxid Redox Signal       Date:  2009-08       Impact factor: 8.401

10.  Differential requirement of CAAX-mediated posttranslational processing for Rheb localization and signaling.

Authors:  A B Hanker; N Mitin; R S Wilder; E P Henske; F Tamanoi; A D Cox; C J Der
Journal:  Oncogene       Date:  2009-10-19       Impact factor: 9.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.